Search by
On December 2, 2025, Morphocell Technologies Inc. announced it completed US$50-million Series A financing following a US$10-million add-on led by Investissement Québec.
Morphocell Technologies Inc. is a biotechnology company.
Osler, Hoskin & Harcourt LLP advised Morphocell Technologies Inc. with a team consisting of Nathalie Beauregard, Chris Yangchen Wu and Marissa Kyres (Emerging and High Technology Companies).
Parties
Company
Morphocell Technologies Inc.
Company
Investissement Québec
Deal Type
Financing/InvestmentIndustry
HealthcareTransaction
$ 68,801,817Deal Status
ClosedClosing Date
02 December 2025